Home›Antibody-drug conjugates›Ozogamicina inotuzumab🌐EspañolEnglishDeutschEspañolFrançaisItalianoNederlandsРусскийالعربية日本語EntityQ3799041· pop 9· linked from 351 articlesOzogamicina inotuzumabAlso known as inotuzumabcompuesto químicoResearch540 papersInotuzumab Ozogamicin.2012Inotuzumab Ozogamicin.2006Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial.The Lancet. Haematology · 2023Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.The New England journal of medicine · 2016Inotuzumab Ozogamicin: First Pediatric Approval.Paediatric drugs · 2024via PubMedAvailable in 9 languagesEspañolFrançaisDeutsch日本語РусскийItalianoالعربيةOdiavia Wikidata sitelinks · CC0Connectionshumanized antibodyEntityfusion proteinEntityCategoriesAntibody-drug conjugatesChemicals that do not have a ChemSpider ID assignedDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs developed by PfizerDrugs developed by WyethDrugs that are a monoclonal antibodyDrugs with non-standard legal statusMonoclonal antibodies for tumorsOrphan drugsSource attribution